A randomized, double-blind, placebo-controlled investigation of BCc1 nanomedicine effect on survival and quality of life in metastatic and non-metastatic gastric cancer patients

BACKGROUND: Currently, the main goal of cancer research is to increase longevity of patients suffering malignant cancers. The promising results of BCc1 in vitro and vivo experiments made us look into the effect of BCc1 nanomedicine on patients with cancer in a clinical trial. METHODS: The present in...

Descripción completa

Detalles Bibliográficos
Autores principales: Hafizi, Maryam, Kalanaky, Somayeh, moaiery, Hassan, Khayamzadeh, Maryam, Noorian, Sajad, Kaveh, Vahid, Gharib, Behrooz, Foudazi, Hossein, Razavi, Mohsen, Jenabian, Arash, Salimi, Saeid, Sereshki, Mohammad Mahdi Adib, Mirzaei, Hamid Reza, Zarghi, Afshin, Fakharzadeh, Saideh, Nazaran, Mohammad Hassan, Akbari, Mohammad Esmaeil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458717/
https://www.ncbi.nlm.nih.gov/pubmed/30971278
http://dx.doi.org/10.1186/s12951-019-0484-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458717/
https://www.ncbi.nlm.nih.gov/pubmed/30971278
http://dx.doi.org/10.1186/s12951-019-0484-0

Ejemplares similares